REQUEST A DEMO
Total
USD $0.00
Search more companies

Gomez Castellanos Jose Eugenio (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Gomez Castellanos Jose Eugenio Profile Updated: October 19, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Gomez Castellanos Jose Eugenio is based in Colombia. The head office is in Giron. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on July 21, 1995. The total number of employees is currently 1 (2023). There was a net sales revenue drop of 78.43% reported in Gomez Castellanos Jose Eugenio’s latest financial highlights for 2022. In, 2022, the company’s net profit margin decreased by 875.52%.

Headquarters
Centro Logistico San Jorge Km. 7 - 400 Anillo Via Palenque Diagonal Floridablanca # 22-31 Bodega 92
Giron; Santander;

Contact Details: Purchase the Gomez Castellanos Jose Eugenio report to view the information.

Website: http://www.disfarma.com.co

Basic Information
Total Employees:
Purchase the Gomez Castellanos Jose Eugenio report to view the information.
Outstanding Shares:
Purchase the Gomez Castellanos Jose Eugenio report to view the information.
Incorporation Date:
July 21, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Gomez Castellanos Jose Eugenio report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-78.43%
Total operating revenue
-78.43%
Net Profit (Loss) for the Period
-98.89%
Total assets
0%
Total equity
-6.78%
Net Profit Margin
-875.52%
Return on Equity (ROE)
-29.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?